Stay updated on T-Cell PET Imaging in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the T-Cell PET Imaging in Lung Cancer Clinical Trial page.

Latest updates to the T-Cell PET Imaging in Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe record describes a Phase 2 study of [18F]F-AraG PET imaging in people with localized non-small cell lung cancer receiving pembrolizumab, with or without stereotactic radiation. It is listed as withdrawn with low accrual and no results posted.SummaryDifference41%

- Check10 days agoChange DetectedThe ClinicalTrials.gov study page still shows a 403 Forbidden error; the footer revision identifier changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check17 days agoChange DetectedA banner announces an NIH website transition and says some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check24 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check31 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1, with the study page still displaying a 403 error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previously visible study content. The study details and related sections have been removed, leaving only site-wide chrome and footer information.SummaryDifference17%

Stay in the know with updates to T-Cell PET Imaging in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-Cell PET Imaging in Lung Cancer Clinical Trial page.